Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers

Biological Psychiatry

Volumn 45, Issue 11, 1999, Pages 1447-1454

  Scott, Lucinda V ^a   Medbak, Sami ^b   Dinan, Timothy G ^c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Adrenocorticotropin; Chronic fatigue syndrome; Corticotropin releasing hormone; Cortisol; Desmopressin; Hypothalamic pituitary adrenal axis; Vasopressin

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DESMOPRESSIN; HYDROCORTISONE; VASOPRESSIN;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; CORTICOTROPIN TEST; FEMALE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORTICOTROPIN-RELEASING HORMONE; DEAMINO ARGININE VASOPRESSIN; DRUG INTERACTIONS; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RENAL AGENTS;

EID: 0032881852     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00232-7     Document Type: Article

References (46)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. 1987;American Psychiatric Press, Washington, DC.
2. Andersson K.E., Arner B., Hedner P., Mulder J.L. Effects of 8-lysine vasopressin and synthetic analogues on release of ACTH. Acta Endocrinol. 69:1972;640-648.
3. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol. 14:1993;76-122.
4. Bakheit A.M., Behan P.O., Watson W.S., Morton J.J. Abnormal arginine vasopression secretion and water metabolism in patients with post-viral fatigue syndrome. Acta Neurol Scand. 87:1993;234-238.
5. Bearn J., Allain T., Coskeran P., Munro N., Butler J., McGregor A. Neuroendocine responses to D-fenfluramine and insulin-induced hypoglycaemia in chronic fatigue syndrome. Biol Psychiatry. 37:1995;245-252.
6. Brostoff J., James V.H.T., Landon J. Plasma corticosteroid and growth hormone response to lysine-vasopressin in man. J Clin Endocrinol Metab. 28:1968;511-518.
7. Calogero A., Sternberg E., Bagdy G. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: In vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology. 55:1992;600-608.
8. Ceserini G., Freddi M., Paccotti P., Valenti G., Merchenthaler I. Effects of ovine corticotropin-releasing hormone injection and desmopressin coadministration on galanin and adrenocorticotropin plasma levels in normal women. J Clin Endocrinol Metab. 82:1997;607-610.
9. Chrousos G.P., Gold P.W. The concepts of stress and stress system disorders. JAMA. 267:1992;1244-1252.
10. Cleare A.J., Bearn J., Allain T., et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord. 35:1995;283-289.
11. Crofford L., Pillemer S., Kalageros K., et al. Hypothalamic pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheumatol. 37:1994;1583-1592.
12. Dash R., England B., Rees Midgeley A, Niswende G. A specific, nonchromatographic radioimmunoassay for human plasma cortisol steroids. Steroids. 26:1975;647-661.
13. DeBold C.R., Sheldon W.R., DeCherney G.S., et al. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest. 73:1984;533-538.
14. Demitrack M.A. Neuroendocrine correlates of chronic fatigue syndrome: A brief review. J Psychiatr Res. 31:1997;69-82.
15. Demitrack M.A., Dale J.K., Laue L., et al. Evidence for impaired activation of the pituitary-adrenal axis in chronic fatigue syndrome. J Clin Endocrinol Metab. 73:1991;1224-1234.
16. Dinan T.G., Majeed T., Lavelle E., Scott L.V., Berti C., Behan P. Serotonin-mediated activation of the hypothalamic-pituitary adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology. 22:1997;261-267.
17. Favrod-Coune C., Raux-Demay M., Proeschel M., et al. Potentiation of the classic ovine corticotropin-releasing hormone test by the combined administration of small doses of lysine vasopressin. Clin Endocrinol. 38:1993;405-410.
18. Foppiani L., Sessarego P., Valenti S., et al. Lack of effect of desmopressin on ACTH and cortisol responses to ovine corticotropin-releasing hormone in anorexia nervosa. Eur J Clin Invest. 26:1996;879-883.
19. Fukuda K., Straus S.E., Hickie I., Sharpe M., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its treatment and study. Ann Intern Med. 12:1994;953-959.
20. Gaillard R.C., Riondal A.M., Ling N., Muller A.F. Corticotropin-releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin. Life Sci. 43:1988;1935-1944.
21. Giguere V., Labrie F., Cote C., Coy D.H., Sueiras-Diaz J., Schally A.V. Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat: Site of glucocorticoid action. Proc Natl Acad Sci USA. 79:1982;34966-34969.
22. Gold P., Gwirstman H., Averginos P., et al. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa: Pathophysiological mechanisms in normal and underweight patients. N Engl J Med. 314:1986;1335-1342.
23. Guillon G., Trueba M., Joubert D., et al. Vasopressin stimulates steroid secretion in human adrenal glands: Comparison with angiotensin II effect. Endocrinology. 136:1995;1285-1295.
24. Holsboer F., von Bardeleben U., Gerken A., Stalla G.K., Muller O.A. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor (hCRF) in depression. N Engl J Med. 311:1984;1127.
25. Holsboer F., Gerken A., Steiger A., Benkert O., Muller O.A., Stalla G.K. Corticotropin-releasing factor induced pituitary-adrenal responses in depression. Lancet. i:1984;55.
26. Kasagi Y, Suda T, Horiba N, et al: DDAVP test for the diagnosis of ACTH-dependant Cushings syndrome. In: Proceedings of the 76th Annual Meeting of the Endocrine Society, Washington DC. Bethesda, MD: Endocrine Society, 1994: p 99.
27. Lamberts S., Verleun T., Oosterom R., de Jong F., Hackeng W. Corticotropin-releasing factor (ovine) and vasopressin exert synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab. 57:1984;298-303.
28. Liu J.H., Muse K., Contreras P., et al. Augmentation of ACTH-releasing factor (CRF) by vasopressin in women. J Clin Endocrinol Metab. 57:1983;1087-1089.
29. Malerbi D.A., Mendonca B., Liberman B., et al. The desmopressin stimulation test in the differential diagnosis of Cushings disease. Clin Endocrinol. 38:1993;463-472.
30. Nemeroff C.B., Widerlov E., Bissette G., et al. Elevated concentrations of corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
31. Patchev V., Kalogeras K., Zelazowski P., Wilder R., Chrousos G. Increased plasma concentration, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone hypothalamic corticotropin-hormone deficient Lewis rats. Endocrinology. 131:1992;1453-1457.
32. Perraudin V., Delarue C., Lefevre H., Contesse V., Kuhn J.M., Vaudry H. Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors. J Clin Endocrinol Metab. 76:1993;1522-1528.
33. Purba J., Hoogendijk W., Hofman M., Swaab D. Increased numbers of vasopressin and oxytocin expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry. 53:1996;137-143.
34. Rabadan-Diehl C., Lolait S., Aguilera G. Regulation of pituitary V1b receptor mRNA during stress in the rat. J Neuroendocrinol. 7:1995;903-910.
35. Rado J.S., Juhos E. Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on plasma cortisol (hydrocortisone ). J Clin Pharmacol. 16:1976;333-337.
36. Raff H., Findling J. A new immunoradiometric assay for corticotropin, evaluated in normal subjects and patients with Cushings syndrome. Clin Chem. 35:1989;595-600.
37. Salata R.A., Jarrett D.B., Verbalis J.G., Robinson A.G. Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. J Clin Invest. 81:1988;766-774.
38. Sawyer W.H., Acosta M., Balaspiri L., Judd J., Manning M. Structural changes in the arginine vasopressin molecule. Endocrinology. 94:1974;1106-1115.
39. Scott L.V., Medbak S., Dinan T.G. Blunted adrenocorticotropin and cortisol responses to corticotropin releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand. 97:1998;450-457.
40. Scott L.V., Medbak S., Dinan T.G. The low dose ACTH test in chronic fatigue syndrome and in health. Clin Endocrinol. 48:1998;733-737.
41. Spitzer R., Williams J., Gibbon M. Structured Clinical Interview for DSM III-R. 1987;New York State Psychiatric Institute, Biometrics Research, New York.
42. Sternberg E., Hill J., Chrousos G., et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats. Proc Natl Acad Sci USA. 86:1989;4771-4775.
43. Sugimoto Y., Sato M., Mochizuki S., et al. Molecular cloning and functional characterization of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem. 269:1994;27088-27092.
44. Todd B.K., Lawrence C. The Cushing syndrome: An update on diagnostic tests. Ann Intern Med. 112:1990;434-444.
45. Whitnall M.H. Stress selectively activates the vasopressin-containing subpopulations of corticotropin-releasing hormone neurons. Neuroendocrinology. 50:1989;702-707.
46. Winkelmann W., Heppner C., Schmitt H.W., Deuss U., Nieke D., Kaulen D. The desmopressin stimulation test in patients with ACTH hypersecretion. Eur J Endocrinol. 130:(suppl 2):1994;151.